Lawrence Engmann, M.D., M.R.C.O.G. and Claudio Benadiva, M.D., H.C.L.D.
Volume 97, Issue 3, Pages 531-533
Although gonadotropin-releasing hormone agonist (GnRHa) trigger is effective in the prevention of ovarian hyperstimulation syndrome, lower conception rates have been reported. Intensive luteal phase support is an effective approach to improve implantation rates in women with peak E2 levels ≥4,000 pg/mL. However, patients with peak E2 levels
Read the full text at: http://www.fertstert.org/article/S0015-0282(11)02904-9/fulltext